Literature DB >> 19217108

Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.

Bart Lammers1, Ruud Out, Reeni B Hildebrand, Carmel M Quinn, David Williamson, Menno Hoekstra, Illiana Meurs, Theo J C Van Berkel, Wendy Jessup, Miranda Van Eck.   

Abstract

OBJECTIVE: ATP-binding cassette transporter G1 (Abcg1) and apolipoprotein E (Apoe) play a role in macrophage cholesterol efflux and consequently the development of atherosclerosis. A possible interaction between Abcg1 and Apoe in cholesterol efflux was postulated, but the potential combined action of these proteins on atherosclerotic lesion formation is unclear.
METHODS: LDL receptor knockout (KO) mice were transplanted with bone marrow from Abcg1/Apoe double KO (dKO) mice, their respective single knockouts, and wild-type (WT) controls and challenged with a high-fat/high-cholesterol diet for 6 weeks to induce atherosclerosis.
RESULTS: No differences were found in serum lipid levels. The mean atherosclerotic lesion area in dKO transplanted animals (187+/-18x10(3)microm(2)) was 1.4-fold (p<0.01) increased compared to single knockouts (Abcg1 KO: 138+/-5x10(3)microm(2); Apoe KO: 131+/-7x10(3)microm(2)) and 1.9-fold (p<0.001) as compared to WT controls (97+/-15x10(3)microm(2)). In vitro cholesterol efflux experiments established that combined deletion of Abcg1 and Apoe leads to a larger attenuation of macrophage cholesterol efflux to HDL as compared to single knockouts.
CONCLUSIONS: Single deletion of macrophage Abcg1 or Apoe does lead to a moderate non-significant increase in atherosclerotic lesion development as tested by ANOVA, while combined deletion of Abcg1 and Apoe induces a more dramatic and significant increase in atherosclerosis. Our results indicate an additive, independent effect for both macrophage Abcg1 and Apoe in the prevention of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217108     DOI: 10.1016/j.atherosclerosis.2009.01.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Impaired development of atherosclerosis in Abcg1-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in Abcg1-/- Apoe-/- tissues and induce apoptosis.

Authors:  Elizabeth J Tarling; Dragana D Bojanic; Rajendra K Tangirala; Xuping Wang; Anita Lovgren-Sandblom; Aldons J Lusis; Ingemar Bjorkhem; Peter A Edwards
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

Review 2.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 3.  ABC transporters, atherosclerosis and inflammation.

Authors:  Michael L Fitzgerald; Zahedi Mujawar; Norimasa Tamehiro
Journal:  Atherosclerosis       Date:  2010-01-21       Impact factor: 5.162

4.  Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.

Authors:  Bart Lammers; Ying Zhao; Menno Hoekstra; Reeni B Hildebrand; Dan Ye; Illiana Meurs; Theo J C Van Berkel; Miranda Van Eck
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

5.  Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits.

Authors:  Götz Münch; Andreas Bültmann; Zhongmin Li; Hans-Peter Holthoff; Julia Ullrich; Silvia Wagner; Martin Ungerer
Journal:  Heart Int       Date:  2012-06-25

6.  Leukocytosis and enhanced susceptibility to endotoxemia but not atherosclerosis in adrenalectomized APOE knockout mice.

Authors:  Menno Hoekstra; Vanessa Frodermann; Tim van den Aardweg; Ronald J van der Sluis; Johan Kuiper
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

Review 7.  Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.

Authors:  Bee Kee Ooi; Bey Hing Goh; Wei Hsum Yap
Journal:  Int J Mol Sci       Date:  2017-11-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.